Kenneth G. Langone - 03 Dec 2025 Form 4 Insider Report for UNIFI INC (UFI)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
05 Dec 2025, 16:20:09 UTC
Prior SEC filing
03 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ WESLEY M. SUTTLE, attorney-in-fact

Key filing fact

Kenneth G. Langone filed Form 4 for UNIFI INC (UFI) on 05 Dec 2025.

Key facts

  • This page summarizes Kenneth G. Langone's Form 4 filing for UNIFI INC (UFI).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 05 Dec 2025, 16:20.

Change

  • Previous filing in this sequence was filed on 03 Dec 2025.
  • Current net transaction value: +$229,852.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0000905874 Primary reporting owner

LANGONE KENNETH G

Relationship
Director, 10%+ Owner
Address
375 PARK AVENUE, STE 2205, NEW YORK
Signature
/s/ WESLEY M. SUTTLE, attorney-in-fact
Signature date
05 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

UFI transaction

Common Stock

Purchase

Transaction value
$141,578
Shares
+40,451
Change %
+1.7%
Price
$3.50
Shares after
2,466,245
Date
03 Dec 2025
Ownership
Direct
Footnotes
F1
UFI transaction

Common Stock

Purchase

Transaction value
$88,274
Shares
+25,811
Change %
+1%
Price
$3.42
Shares after
2,492,056
Date
04 Dec 2025
Ownership
Direct
Footnotes
F2
UFI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
30,000
Date
03 Dec 2025
Ownership
By wife
Footnotes
F3
UFI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
130,000
Date
03 Dec 2025
Ownership
By Invemed Associates LLC
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.35 to $3.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.26 to $3.55, inclusive.

Footnote F3

The reporting person disclaims beneficial ownership of these securities, and this Form 4 shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Footnote F4

The reporting person is the principal equity holder and previously served as Chairman and CEO of Invemed Associates LLC. Pursuant to Instruction (4)(b)(iv) of Form 4, the reporting person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by such entity. The reporting person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or are not actually distributed to him.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .